Topical and Transdermal Benefits of Nanostructured Lipid Carriers

Order of Publishing in Issue: 
Volume :13
Issue :2
April, 2019 - June, 2019
Page No: 
Ashwini M*, Srividya R, Shaanya Johl
Krupanidhi College of Pharmacy, 12/1, Chikkabellandur, Carmelaram, Post, Varthur Hobli, Bengaluru - 560 035

Lipid based carriers (solid lipid nanoparticles-SLN and nanostructured lipid carriers-NLC) were developed at the beginning of the 90s and has been extensively used for topical and transdermal delivery of pharmaceuticals and cosmeceuticals. Among them, NLC’s are widely accepted for maintaining drug stability, improving drug therapy, solubilizing poorly water soluble drugs, achieving controlled and sustained drug delivery and reduced toxicity. This review article discusses different formulations and characterization techniques and discusses how NLCs can penetrate the skin barrier. Further, overview on the current state of the art of NLCs as therapeutic and cosmetic formulations are also discussed in detail. The study highlights the reported data on oral bioavailability and toxicological studies and how these NLC’s can be employed as promising drug delivery systems for novel treatments in the near future.

Nanostructured Lipid Carrier, transdermal drug delivery, topical drug delivery nanoparticles, penetration.
PDF1.25 MB

To download full text articles and issues in PDF at no cost.All you have to do is fill out a brief registration form. It's easy and it's free. At any time, you may request removal of your contact information from our database.
Click here to Register | Click here if you have already registered

2018 ABAP Awards

Invitation for Nominations to 2019 ABAP Awards
The Association of Biotechnology and Pharmacy invites nominations for the following awards from the eligible talented people with proven track record and achievements on or before August 31, 2019 in the prescribed format.



Upcoming 0 events

  • No upcoming events available

User login